1. Home
  2. OGN vs SXI Comparison

OGN vs SXI Comparison

Compare OGN & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • SXI
  • Stock Information
  • Founded
  • OGN 1923
  • SXI 1955
  • Country
  • OGN United States
  • SXI United States
  • Employees
  • OGN N/A
  • SXI N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • SXI Industrial Machinery/Components
  • Sector
  • OGN Health Care
  • SXI Industrials
  • Exchange
  • OGN Nasdaq
  • SXI Nasdaq
  • Market Cap
  • OGN 2.5B
  • SXI 2.3B
  • IPO Year
  • OGN N/A
  • SXI N/A
  • Fundamental
  • Price
  • OGN $9.93
  • SXI $163.12
  • Analyst Decision
  • OGN Hold
  • SXI Strong Buy
  • Analyst Count
  • OGN 4
  • SXI 3
  • Target Price
  • OGN $18.00
  • SXI $223.33
  • AVG Volume (30 Days)
  • OGN 3.6M
  • SXI 141.5K
  • Earning Date
  • OGN 08-05-2025
  • SXI 07-31-2025
  • Dividend Yield
  • OGN 0.80%
  • SXI 0.79%
  • EPS Growth
  • OGN N/A
  • SXI N/A
  • EPS
  • OGN 2.88
  • SXI 5.04
  • Revenue
  • OGN $6,294,000,000.00
  • SXI $748,252,000.00
  • Revenue This Year
  • OGN N/A
  • SXI $9.67
  • Revenue Next Year
  • OGN $1.11
  • SXI $12.91
  • P/E Ratio
  • OGN $3.45
  • SXI $32.38
  • Revenue Growth
  • OGN N/A
  • SXI 2.67
  • 52 Week Low
  • OGN $8.01
  • SXI $128.85
  • 52 Week High
  • OGN $23.10
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • OGN 51.13
  • SXI 55.30
  • Support Level
  • OGN $9.71
  • SXI $163.30
  • Resistance Level
  • OGN $10.27
  • SXI $169.98
  • Average True Range (ATR)
  • OGN 0.37
  • SXI 4.51
  • MACD
  • OGN 0.01
  • SXI 0.39
  • Stochastic Oscillator
  • OGN 48.48
  • SXI 56.05

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

Share on Social Networks: